Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma

Therapies based on immune checkpoint inhibitors (ICPI) have yielded promising albeit limited results in patients with hepatocellular carcinoma (HCC). Vaccines have been proposed as combination partners to enhance response rates to ICPI. Thus, we analyzed the combined effect of a vaccine based on the...

Full description

Bibliographic Details
Main Authors: Leyre Silva, Josune Egea, Lorea Villanueva, Marta Ruiz, Diana Llopiz, David Repáraz, Belén Aparicio, Aritz Lasarte-Cia, Juan José Lasarte, Marina Ruiz de Galarreta, Amaia Lujambio, Bruno Sangro, Pablo Sarobe
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cancers
Subjects:
cold-inducible RNA binding protein
therapeutic vaccination
hepatocellular carcinoma
immune checkpoint inhibitors
Online Access:https://www.mdpi.com/2072-6694/12/11/3397

Internet

https://www.mdpi.com/2072-6694/12/11/3397

Similar Items